Core C The role of the Protein and Small Molecule Chemistry Core is central to the needs of all the investigators in the Program Project Proposal. The Core will provide project investigators access to purified proteins and virus-like particle (VLPs) as well as custom synthesis of small molecules and peptides. The Core will also construct mutant versions of proteins by site-directed mutagenesis as needed by investigators. Finally, the Core will characterize and quantitate protein-protein and protein-ligand interactions. Examples of Core activities include purification of norovirus protease to facilitate drug discovery and purification of VLPs for investigations of antibody interactions with capsid. Activities also include synthesis of small molecule protease inhibitor candidates for biochemical and cell-based testing as well as structural studies. In addition, the Core will measure binding affinity of small molecules with norovirus protease as well as affinity of antibody-VLP interactions and other protein-protein interactions as needed by project investigators. Finally, the Core will construct site-directed mutations in the norovirus protease, p22, and p41 genes and others as needed for functional studies by project investigators. The Core personnel have extensive experience in the methods required for providing these services and all of the equipment and resources necessary are available in the Core. The performance of services such as protein purification and small molecule synthesis, mutagenesis, and binding measurements in a Core facility avoids the need for individual investigators to acquire the necessary expertise and equipment and is an efficient means of facilitating progress on the scientific goals of the project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI057788-11
Application #
8855692
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2015-06-01
Budget End
2016-05-31
Support Year
11
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Alvarado, Gabriela; Ettayebi, Khalil; Atmar, Robert L et al. (2018) Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology 155:1898-1907
Costantini, Veronica; Morantz, Esther K; Browne, Hannah et al. (2018) Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation. Emerg Infect Dis 24:1453-1464
Bányai, Krisztián; Estes, Mary K; Martella, Vito et al. (2018) Viral gastroenteritis. Lancet 392:175-186
Cortes-Penfield, Nicolas W; Ramani, Sasirekha; Estes, Mary K et al. (2017) Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther 39:1537-1549
Ramani, Sasirekha; Neill, Frederick H; Ferreira, Jennifer et al. (2017) B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol 24:
Hurwitz, Amy M; Huang, Wanzhi; Estes, Mary K et al. (2017) Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel 30:129-139
Sharma, Sumit; Carlsson, Beatrice; Czakó, Rita et al. (2017) Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades. J Virol 91:
Shanker, Sreejesh; Hu, Liya; Ramani, Sasirekha et al. (2017) Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol 44:211-218
Zou, Winnie Y; Blutt, Sarah E; Crawford, Sue E et al. (2017) Human Intestinal Enteroids: New Models to Study Gastrointestinal Virus Infections. Methods Mol Biol :
Yu, Huimin; Hasan, Nesrin M; In, Julie G et al. (2017) The Contributions of Human Mini-Intestines to the Study of Intestinal Physiology and Pathophysiology. Annu Rev Physiol 79:291-312

Showing the most recent 10 out of 98 publications